These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9042985)

  • 1. The safety of ranitidine in over a decade of use.
    Mills JG; Koch KM; Webster C; Sirgo MA; Fitzgerald K; Wood JR
    Aliment Pharmacol Ther; 1997 Feb; 11(1):129-37. PubMed ID: 9042985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of increasing doses of ranitidine for treatment of heartburn.
    Pappa KA; Buaron K; Payne JE; Sirgo MA; Giefer EE
    Aliment Pharmacol Ther; 1999 Apr; 13(4):475-81. PubMed ID: 10215731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonprescription doses of ranitidine are effective in the relief of episodic heartburn.
    Ciociola AA; Pappa KA; Sirgo MA
    Am J Ther; 2001; 8(6):399-408. PubMed ID: 11704778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of the nonprescription drug consumer's understanding of the ranitidine product label and actual product usage patterns in the treatment of episodic heartburn.
    Ciociola AA; Sirgo MA; Pappa KA; McGuire JA; Fung K
    Am J Ther; 2001; 8(6):387-98. PubMed ID: 11704777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lansoprazole compared with ranitidine for the treatment of nonerosive gastroesophageal reflux disease.
    Richter JE; Campbell DR; Kahrilas PJ; Huang B; Fludas C
    Arch Intern Med; 2000 Jun; 160(12):1803-9. PubMed ID: 10871974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse reactions to H2-receptor antagonists in Denmark before and after transfer of cimetidine and ranitidine to over-the-counter status.
    Andersen M; Schou JS
    Pharmacol Toxicol; 1991 Oct; 69(4):253-8. PubMed ID: 1683484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety profile of H2-receptor antagonists: current status of famotidine.
    Levine JB
    J Int Med Res; 1989; 17 Suppl 1():48A-53A. PubMed ID: 2566543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose ranitidine for the relief of heartburn.
    Pappa KA; Gooch WM; Buaron K; Payne JE; Giefer EE; Sirgo MA; Ciociola AA
    Aliment Pharmacol Ther; 1999 Apr; 13(4):459-65. PubMed ID: 10215729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adverse effects of ulcer drugs before and after release of cimetidine, ranitidine and sucralfate for over-the-counter sale].
    Andersen M; Schou JS
    Ugeskr Laeger; 1991 May; 153(20):1410-3. PubMed ID: 1674181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rhinitis and asthma due to ranitidine.
    Martínez AJ; Callejo Melgosa A; Fuentes GM; Martín García C
    J Investig Allergol Clin Immunol; 2006; 16(2):142-3. PubMed ID: 16689191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standard-dose lansoprazole is more effective than high-dose ranitidine in achieving endoscopic healing and symptom relief in patients with moderately severe reflux oesophagitis. The Dutch Lansoprazole Study Group.
    Jansen JB; Van Oene JC
    Aliment Pharmacol Ther; 1999 Dec; 13(12):1611-20. PubMed ID: 10594396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The management of acid-related dyspepsia in general practice: a comparison of an omeprazole versus an antacid-alginate/ranitidine management strategy. Compete Research Group [corrected].
    Mason I; Millar LJ; Sheikh RR; Evans WM; Todd PL; Turbitt ML; Taylor MD
    Aliment Pharmacol Ther; 1998 Mar; 12(3):263-71. PubMed ID: 9570261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating H. pylori and reducing ulcer recurrence. RBC H. pylori Study Group.
    Peterson WL; Ciociola AA; Sykes DL; McSorley DJ; Webb DD
    Aliment Pharmacol Ther; 1996 Jun; 10(3):251-61. PubMed ID: 8791947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rabeprazole versus ranitidine for the treatment of erosive gastroesophageal reflux disease: a double-blind, randomized clinical trial. Raberprazole Study Group.
    Farley A; Wruble LD; Humphries TJ
    Am J Gastroenterol; 2000 Aug; 95(8):1894-9. PubMed ID: 10950032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Possibly ranitidine-induced autoimmune hepatitis].
    Luparini RL; Rotundo A; Mattace R; Marigliano V
    Ann Ital Med Int; 2000; 15(3):214-7. PubMed ID: 11059062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind, placebo-controlled study of the efficacy and safety of non-prescription ranitidine 75 mg in the prevention of meal-induced heartburn.
    Pappa KA; Williams BO; Payne JE; Buaron KS; Mussari KL; Ciociola AA
    Aliment Pharmacol Ther; 1999 Apr; 13(4):467-73. PubMed ID: 10215730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lichenoid eruptions due to the H2-receptor antagonists roxatidine and ranitidine.
    Horiuchi Y; Katagiri T
    J Dermatol; 1996 Jul; 23(7):510-2. PubMed ID: 8772037
    [No Abstract]   [Full Text] [Related]  

  • 19. Heartburn-dominant, uninvestigated dyspepsia: a comparison of 'PPI-start' and 'H2-RA-start' management strategies in primary care--the CADET-HR Study.
    Armstrong D; Veldhuyzen van Zanten SJ; Barkun AN; Chiba N; Thomson AB; Smyth S; Sinclair P; Chakraborty B; White RJ;
    Aliment Pharmacol Ther; 2005 May; 21(10):1189-202. PubMed ID: 15882239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case report: ranitidine-induced bradycardia in a patient with dextrocardia.
    Yang J; Russell DA; Bourdeau JE
    Am J Med Sci; 1996 Sep; 312(3):133-5. PubMed ID: 8783681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.